✦ LIBER ✦

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

✍ Scribed by Clayton D. Harro; Robert F. Betts; Jonathan S. Hartzel; Matthew T. Onorato; Joy Lipka; Steven S. Smugar; Nicholas A. Kartsonis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

109 The Immunogenicity and Safety of a N

✍ Moustafa Moustafa; John Buerkert; Tarek Sobeih; Claude Galphin; Gaspar Barreto-T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Safety and immunogenicity of the modifie

✍ A. Loew-Baselli; R. Konior; B.G. Pavlova; S. Fritsch; E. Poellabauer; F. Maritsc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 174 KB

A Phase I, randomized, open-label study

✍ Cheng, Aristine; Fung, Chang-Phone; Liu, Chia-Chyi; Lin, Yi-Tsung; Tsai, Hsih-Ye 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 768 KB

A phase I/IIa safety, immunogenicity, an

✍ Kent E. Kester; Denise A. McKinney; Nadia Tornieporth; Christian F. Ockenhouse; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

A comparative study to evaluate the safe

✍ Siddhivinayak Hirve; Ashish Bavdekar; Sanjay Juvekar; Dhiraj Agarwal; Prajakt Ba 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 215 KB

729 POSTER Safety, maximum tolerated dos

✍ N. Loman; O. Borgå; S. Lindberg; S. Pettersson; R. Henriksson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB